Bio-Path Holdings Inc Analysis
| Analyst Ratings |
|
Average Target Price
|
11.00
|
|
Average Rating
|
4.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.45
|
-0.49
|
-0.04
|
-8.89%
|
|
2022-06-30
|
-0.49
|
-0.42
|
0.07
|
14.29%
|
|
2022-03-31
|
-0.45
|
-0.47
|
-0.02
|
-4.44%
|
|
2021-12-31
|
-0.32
|
-0.59
|
-0.27
|
-84.38%
|
|
2021-09-30
|
-0.33
|
-0.29
|
0.04
|
12.12%
|
|
2021-06-30
|
-0.39
|
-0.26
|
0.13
|
33.33%
|
|
2021-03-31
|
-0.49
|
-0.43
|
0.06
|
12.24%
|
|
2020-12-31
|
-0.78
|
-0.57
|
0.21
|
26.92%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.38
|
|
2021-12-31
|
-1.57
|
|
2020-12-31
|
-2.82
|
|
2019-12-31
|
-3.27
|
|
2018-12-31
|
-26.18
|
|
2017-12-31
|
-12.20
|
|
2016-12-31
|
-0.90
|
|
2015-12-31
|
-0.25
|
|
2014-12-31
|
-23.16
|
|
2010-12-31
|
-7.94
|
|
2009-12-31
|
-9.28
|
|
2008-12-31
|
-11.19
|
|
2007-12-31
|
-14.07
|
|
2006-12-31
|
-15.09
|